Harry Macdannald, MD
Pulmonary Disease · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Office
- 1
- Since medical school
- 54 years
- University of California, Davis School of Medicine, 1972
Offices
1 location · Jiva Health Inc · 46 clinicians in this group
Hospitals listed: John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Macdannald’s office at (925) 685-4224 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G26701 · Current
Licensed to practise in California · since 1974 · expires 2027-10-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Pulmonary Disease
- American Board of Internal Medicine - Sleep Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$248,205
Medicare paid this office $248,205 for 825 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 606 | $93,800 | $106 |
| Sleep study in sleep lab (6 years or older) | 77 | $51,167 | $665 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 46 | $37,767 | $699 |
| New patient visit (45+ min) | 236 | $32,041 | $136 |
| Sleep study including heart rate, breathing, and sleep time | 82 | $23,721 | $145 |
See all 11 services
| Return visit (30+ min) | 606 | $93,800 | $106 |
| Sleep study in sleep lab (6 years or older) | 77 | $51,167 | $665 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 46 | $37,767 | $699 |
| New patient visit (45+ min) | 236 | $32,041 | $136 |
| Sleep study including heart rate, breathing, and sleep time | 82 | $23,721 | $145 |
| Long return visit (40+ min) | 34 | $4,516 | $133 |
| Test to determine lung volumes using sensors | 54 | $586 | $11 |
| Test to examine how well the lungs exchange gases | 56 | $444 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 44 | $402 | $9 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $200 | $15 |
| Test to measure expiratory airflow and volume | 12 | $90 | $7 |
Who their Medicare patients are
825 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 43% · Also on Medicaid 17% · Health risk score 1.09. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 74% · Diabetes 28% · Coronary heart disease 25% · Chronic kidney disease 23% · Depression 21% · Atrial fibrillation 20% · COPD 18% · Cancer 16% · Heart failure 11% · Stroke 7% · Dementia 4%.
The office billed $650,714, Medicare allowed $327,534 and paid $248,205; for 1,652 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 825 | 1,652 | 75 | 1.09 | $650,714 | $248,205 |
| 2023 | 761 | 1,356 | 75 | 1.10 | $671,979 | $231,436 |
| 2022 | 736 | 1,410 | 75 | 1.07 | $1,039,095 | $260,084 |
| 2021 | 560 | 1,173 | 75 | 1.14 | $626,440 | $160,332 |
| 2020 | 474 | 866 | 75 | 1.25 | $300,904 | $69,810 |
| 2019 | 649 | 1,325 | 76 | 1.40 | $511,925 | $125,332 |
| 2018 | 748 | 1,912 | 76 | 1.92 | $688,257 | $165,010 |
| 2017 | 729 | 2,048 | 76 | 1.86 | $718,122 | $170,855 |
| 2016 | 717 | 2,261 | 77 | 1.94 | $730,991 | $169,021 |
| 2015 | 824 | 2,548 | 76 | 1.85 | $653,407 | $175,843 |
| 2014 | 745 | 2,246 | 76 | 1.65 | $441,196 | $152,247 |
| 2013 | 680 | 2,053 | 76 | 1.70 | $399,255 | $142,452 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 565 | $78,935 | $101 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 89 | $67,107 | $678 |
| Sleep study in sleep lab (6 years or older) | 55 | $34,896 | $634 |
| New patient visit (45+ min) | 223 | $30,016 | $135 |
| Sleep study including heart rate, breathing, and sleep time | 42 | $12,891 | $155 |
| Long return visit (40+ min) | 26 | $4,273 | $164 |
| Test to determine lung volumes using sensors | 22 | $237 | $11 |
| Test to examine how well the lungs exchange gases | 24 | $191 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $175 | $9 |
2022: 11 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 143 | $100,317 | $664 |
| Return visit (30+ min) | 544 | $89,533 | $107 |
| Sleep study in sleep lab (6 years or older) | 47 | $29,793 | $634 |
| New patient visit (45+ min) | 172 | $24,331 | $141 |
| Sleep study including heart rate, breathing, and sleep time | 53 | $9,139 | $163 |
| Long return visit (40+ min) | 11 | $2,042 | $170 |
| Test to examine how well the lungs exchange gases | 40 | $289 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $186 | $9 |
| Test to determine lung volumes using sensors | 18 | $185 | $10 |
| Test to determine lung volumes using gas dilution or washout | 18 | $184 | $10 |
| Test to measure expiratory airflow and volume | 18 | $111 | $6 |
2021: 9 services
| Return visit (30+ min) | 467 | $94,505 | $114 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 42 | $29,962 | $681 |
| New patient visit (45+ min) | 141 | $20,917 | $148 |
| Sleep study in sleep lab (6 years or older) | 13 | $8,523 | $656 |
| Long return visit (40+ min) | 20 | $3,586 | $163 |
| Test to examine how well the lungs exchange gases | 35 | $287 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $237 | $9 |
| Test to determine lung volumes using sensors | 19 | $222 | $11 |
| Test to determine lung volumes using gas dilution or washout | 14 | $144 | $10 |
2020: 8 services
| Return visit (30+ min) | 406 | $54,356 | $92 |
| New patient visit (45+ min) | 62 | $7,755 | $125 |
| Long return visit (40+ min) | 28 | $3,844 | $113 |
| Test to examine how well the lungs exchange gases | 51 | $454 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 36 | $446 | $12 |
| Test to determine lung volumes using sensors | 26 | $319 | $11 |
| Test to determine lung volumes using gas dilution or washout | 24 | $273 | $11 |
| Test to measure expiratory airflow and volume | 13 | $117 | $8 |
2019: 13 services
| Return visit (30+ min) | 461 | $64,986 | $94 |
| New patient visit (45+ min) | 147 | $20,403 | $139 |
| Long return visit (40+ min) | 72 | $11,532 | $134 |
| New patient visit (60+ min) | 43 | $7,794 | $181 |
| Critical care, first 30-74 minutes | 14 | $2,653 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,797 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,445 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,215 | $53 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 60 | $691 | $12 |
| Test to examine how well the lungs exchange gases | 81 | $671 | $8 |
| Test to determine lung volumes using sensors | 45 | $504 | $11 |
| Test to determine lung volumes using gas dilution or washout | 36 | $404 | $11 |
| Test to measure expiratory airflow and volume | 18 | $153 | $8 |
2018: 16 services
| Return visit (30+ min) | 404 | $50,592 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $25,829 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $19,942 | $91 |
| Critical care, first 30-74 minutes | 61 | $18,803 | $194 |
| New patient visit (45+ min) | 101 | $13,957 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $13,508 | $169 |
| New patient visit (60+ min) | 30 | $5,177 | $173 |
| Long return visit (40+ min) | 40 | $5,059 | $120 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 42 | $2,596 | $33 |
| Diagnostic exam of lung airway using an endoscope | 11 | $1,404 | $117 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,312 | $87 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 53 | $630 | $12 |
| Test to examine how well the lungs exchange gases | 64 | $545 | $8 |
| Test to determine lung volumes using sensors | 35 | $396 | $11 |
| Test to determine lung volumes using gas dilution or washout | 27 | $319 | $11 |
| Test to measure expiratory airflow and volume | 11 | $98 | $8 |
2017: 17 services
| Return visit (30+ min) | 353 | $43,210 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 185 | $32,908 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $21,567 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $19,146 | $174 |
| Critical care, first 30-74 minutes | 65 | $18,439 | $190 |
| New patient visit (45+ min) | 99 | $12,944 | $131 |
| Long return visit (40+ min) | 31 | $3,959 | $120 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 13 | $2,947 | $38 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 27 | $2,803 | $104 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $1,570 | $34 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,566 | $120 |
| Aspiration of fluid from chest cavity | 11 | $938 | $72 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 49 | $552 | $11 |
| Test to examine how well the lungs exchange gases | 63 | $505 | $8 |
| Test to determine lung volumes using gas dilution or washout | 33 | $369 | $11 |
| Test to determine lung volumes using sensors | 32 | $336 | $11 |
| Test to measure expiratory airflow and volume | 14 | $111 | $7 |
2016: 20 services
| Return visit (30+ min) | 379 | $48,335 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 154 | $24,887 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $20,236 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $16,736 | $171 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 21 | $11,374 | $38 |
| New patient visit (60+ min) | 68 | $10,808 | $159 |
| Critical care, first 30-74 minutes | 27 | $6,252 | $184 |
| Long return visit (40+ min) | 31 | $4,188 | $120 |
| New patient visit (45+ min) | 23 | $3,295 | $143 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 16 | $2,738 | $54 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 27 | $2,654 | $98 |
| New patient visit (30+ min) | 22 | $2,117 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,806 | $113 |
| Test for exercise-induced heart and lung stress | 21 | $1,122 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,043 | $34 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 63 | $692 | $11 |
| Test to examine how well the lungs exchange gases | 84 | $649 | $7 |
| Test to determine lung volumes using gas dilution or washout | 48 | $493 | $10 |
| Test to determine lung volumes using sensors | 37 | $387 | $10 |
| Test to measure expiratory airflow and volume | 13 | $80 | $6 |
2015: 20 services
| Return visit (30+ min) | 381 | $50,836 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 143 | $23,261 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 97 | $21,955 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,414 | $171 |
| New patient visit (60+ min) | 70 | $12,697 | $181 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 30 | $9,375 | $37 |
| Critical care, first 30-74 minutes | 25 | $5,772 | $180 |
| New patient visit (45+ min) | 38 | $4,918 | $129 |
| Long return visit (40+ min) | 32 | $4,901 | $129 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 26 | $3,972 | $60 |
| Test for exercise-induced heart and lung stress | 37 | $2,221 | $60 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 175 | $2,018 | $11 |
| Test to examine how well the lungs exchange gases | 200 | $1,597 | $8 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,443 | $103 |
| Test to determine lung volumes using sensors | 117 | $1,262 | $11 |
| Aspiration of fluid from chest cavity | 12 | $1,147 | $82 |
| Test to determine lung volumes using gas dilution or washout | 82 | $898 | $11 |
| Short return visit (20+ min) | 11 | $630 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $535 | $33 |
| Test to measure expiratory airflow and volume | 18 | $132 | $7 |
2014: 16 services
| Return visit (30+ min) | 352 | $39,419 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $22,692 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $18,241 | $174 |
| New patient visit (45+ min) | 114 | $16,160 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $14,184 | $89 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 19 | $10,394 | $38 |
| Short return visit (20+ min) | 100 | $7,899 | $64 |
| Critical care, first 30-74 minutes | 17 | $3,786 | $189 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 13 | $3,054 | $59 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 140 | $1,600 | $11 |
| Long return visit (40+ min) | 12 | $1,533 | $128 |
| Test to examine how well the lungs exchange gases | 147 | $1,179 | $8 |
| Test for exercise-induced heart and lung stress | 19 | $1,145 | $60 |
| Test to determine lung volumes using sensors | 97 | $1,049 | $11 |
| Test to determine lung volumes using gas dilution or washout | 56 | $599 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $403 | $34 |
2013: 17 services
| Return visit (30+ min) | 290 | $34,358 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $24,638 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,426 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $15,719 | $87 |
| New patient visit (45+ min) | 60 | $8,625 | $144 |
| New patient visit (60+ min) | 40 | $7,159 | $179 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 18 | $5,571 | $38 |
| Long return visit (40+ min) | 37 | $4,864 | $125 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 15 | $3,929 | $56 |
| Critical care, first 30-74 minutes | 16 | $3,696 | $185 |
| Test for exercise-induced heart and lung stress | 38 | $2,219 | $58 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 120 | $1,328 | $11 |
| Test to examine how well the lungs exchange gases | 159 | $1,319 | $8 |
| Test to determine lung volumes using sensors | 95 | $1,080 | $11 |
| Short return visit (20+ min) | 12 | $718 | $60 |
| Test to determine lung volumes using gas dilution or washout | 63 | $706 | $11 |
| Test to measure expiratory airflow and volume | 15 | $105 | $7 |
Medicaid work
$70,752 in 2024
Medicaid paid $70,752 for 501 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 257 | $42,821 |
| Return visit (30+ min) | 244 | $27,932 |
| 2024 | 501 | 2 | 32 | $70,752 |
| 2023 | 121 | 2 | 18 | $12,629 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 81 | $9,818 |
| Return visit (30+ min) | 40 | $2,812 |
Drugs they prescribed that Part D paid
$254,988
Pharmacies billed $254,988 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
598 generic and 343 brand-name prescriptions · $254,988 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 147 | $114,050 | $776 |
| Breo Ellipta | 26 | $13,999 | $538 |
| Fluticasone-Salmeterol | 13 | $5,853 | $450 |
| Symbicort | 11 | $3,859 | $351 |
| Albuterol Sulfate Hfa | 94 | $2,707 | $29 |
See all 19 drugs
| Trelegy Ellipta | 147 | $114,050 | $776 |
| Breo Ellipta | 26 | $13,999 | $538 |
| Fluticasone-Salmeterol | 13 | $5,853 | $450 |
| Symbicort | 11 | $3,859 | $351 |
| Albuterol Sulfate Hfa | 94 | $2,707 | $29 |
| Wixela Inhub | 22 | $2,025 | $92 |
| Ventolin Hfa | 12 | $1,354 | $113 |
| Armodafinil | 15 | $1,161 | $77 |
| Modafinil | 30 | $1,112 | $37 |
| Montelukast | 38 | $686 | $18 |
| Trazodone | 114 | $576 | $5 |
| Zolpidem | 59 | $575 | $10 |
| Zolpidem Tartrate Er | 13 | $341 | $26 |
| Clonazepam | 46 | $324 | $7 |
| Alprazolam | 32 | $273 | $9 |
| Gabapentin | 16 | $248 | $15 |
| Prednisone | 37 | $216 | $6 |
| Doxepin | 16 | $164 | $10 |
| Fluticasone Propionate | 13 | $67 | $5 |
Year by year
| 2024 | 941 | 232 | None | 36% | $254,988 |
| 2023 | 876 | 191 | None | 35% | $215,935 |
| 2022 | 684 | 161 | None | None | $248,713 |
| 2021 | 711 | 127 | 0% (0) | 41% | $288,011 |
| 2020 | 858 | 141 | 0% (0) | None | $368,737 |
| 2019 | 1,473 | 211 | 1% (13) | 35% | $330,057 |
| 2018 | 3,531 | 190 | 2% (55) | 24% | $408,618 |
| 2017 | 3,699 | 186 | 1% (52) | 24% | $377,012 |
| 2016 | 3,272 | 185 | 2% (53) | 27% | $332,205 |
| 2015 | 2,675 | 199 | 3% (70) | 27% | $267,858 |
| 2014 | 2,761 | 177 | 3% (76) | 25% | $268,025 |
| 2013 | 1,642 | 159 | 3% (51) | 32% | $191,758 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Trelegy Ellipta | 107 | $75,166 | $702 |
| Breo Ellipta | 48 | $31,694 | $660 |
| Pirfenidone | 11 | $16,885 | $1,535 |
| Symbicort | 15 | $7,943 | $530 |
| Wixela Inhub | 23 | $7,648 | $333 |
| Fluticasone-Salmeterol | 11 | $7,386 | $671 |
| Spiriva Respimat | 11 | $7,216 | $656 |
| Bevespi Aerosphere | 13 | $5,915 | $455 |
| Albuterol Sulfate Hfa | 81 | $3,132 | $39 |
| Ventolin Hfa | 16 | $1,640 | $103 |
| Modafinil | 27 | $1,469 | $54 |
| Armodafinil | 24 | $1,370 | $57 |
| Montelukast | 38 | $1,104 | $29 |
| Ipratropium | 11 | $539 | $49 |
| Trazodone | 79 | $529 | $7 |
| Zolpidem | 43 | $429 | $10 |
| Clonazepam | 42 | $352 | $8 |
| Famotidine | 21 | $311 | $15 |
| Prednisone | 39 | $307 | $8 |
| Doxepin | 12 | $252 | $21 |
| Temazepam | 20 | $127 | $6 |
| Alprazolam | 19 | $113 | $6 |
2022: 21 drugs
| Trelegy Ellipta | 53 | $36,500 | $689 |
| Breo Ellipta | 62 | $29,811 | $481 |
| Spiriva Handihaler | 11 | $13,373 | $1,216 |
| Symbicort | 11 | $11,359 | $1,033 |
| Bevespi Aerosphere | 23 | $10,217 | $444 |
| Wixela Inhub | 19 | $8,563 | $451 |
| Fluticasone-Salmeterol | 16 | $7,145 | $447 |
| Albuterol Sulfate Hfa | 55 | $3,214 | $58 |
| Armodafinil | 21 | $1,884 | $90 |
| Ipratropium | 15 | $1,093 | $73 |
| Montelukast | 32 | $833 | $26 |
| Modafinil | 13 | $795 | $61 |
| Fluticasone Propionate | 11 | $360 | $33 |
| Clonazepam | 33 | $337 | $10 |
| Trazodone | 36 | $320 | $9 |
| Prednisone | 33 | $262 | $8 |
| Zolpidem | 31 | $230 | $7 |
| Lorazepam | 22 | $125 | $6 |
| Famotidine | 12 | $122 | $10 |
| Gabapentin | 13 | $112 | $9 |
| Alprazolam | 12 | $105 | $9 |
2021: 19 drugs
| Breo Ellipta | 81 | $37,818 | $467 |
| Wixela Inhub | 35 | $20,356 | $582 |
| Spiriva | 16 | $17,317 | $1,082 |
| Symbicort | 16 | $14,800 | $925 |
| Trelegy Ellipta | 17 | $14,786 | $870 |
| Bevespi Aerosphere | 24 | $10,151 | $423 |
| Albuterol Sulfate Hfa | 52 | $3,354 | $65 |
| Famotidine | 19 | $2,132 | $112 |
| Armodafinil | 19 | $1,680 | $88 |
| Modafinil | 26 | $857 | $33 |
| Montelukast | 32 | $492 | $15 |
| Trazodone | 37 | $348 | $9 |
| Clonazepam | 34 | $291 | $9 |
| Lorazepam | 31 | $252 | $8 |
| Zolpidem | 33 | $205 | $6 |
| Prednisone | 30 | $196 | $7 |
| Fluticasone Propionate | 13 | $171 | $13 |
| Zolpidem Tartrate Er | 12 | $130 | $11 |
| Pramipexole Dihydrochloride | 11 | $94 | $9 |
2020: 27 drugs
| Ofev | 15 | $160,830 | $10,722 |
| Breo Ellipta | 76 | $33,624 | $442 |
| Trelegy Ellipta | 33 | $24,492 | $742 |
| Spiriva | 23 | $22,087 | $960 |
| Anoro Ellipta | 22 | $16,068 | $730 |
| Wixela Inhub | 30 | $14,547 | $485 |
| Symbicort | 19 | $13,666 | $719 |
| Flovent Hfa | 15 | $7,996 | $533 |
| Famotidine | 41 | $7,067 | $172 |
| Spiriva Respimat | 12 | $6,131 | $511 |
| Eliquis | 26 | $5,423 | $209 |
| Armodafinil | 17 | $3,357 | $197 |
| Albuterol Sulfate Hfa | 34 | $3,023 | $89 |
| Proair Hfa | 15 | $1,769 | $118 |
| Glycopyrrolate | 12 | $795 | $66 |
| Montelukast | 29 | $489 | $17 |
| Fluticasone Propionate | 18 | $488 | $27 |
| Clonazepam | 30 | $347 | $12 |
| Baclofen | 24 | $300 | $13 |
| Prednisone | 32 | $223 | $7 |
| Digoxin | 12 | $187 | $16 |
| Levetiracetam | 17 | $164 | $10 |
| Pramipexole Dihydrochloride | 14 | $160 | $11 |
| Zolpidem | 37 | $157 | $4 |
| Chlorhexidine Gluconate | 20 | $153 | $8 |
| Lorazepam | 21 | $148 | $7 |
| Trazodone | 16 | $86 | $5 |
2019: 45 drugs
| Esbriet | 11 | $72,603 | $6,600 |
| Breo Ellipta | 76 | $36,720 | $483 |
| Spiriva | 34 | $22,336 | $657 |
| Trelegy Ellipta | 23 | $21,081 | $917 |
| Symbicort | 42 | $19,977 | $476 |
| Advair Diskus | 22 | $16,494 | $750 |
| Anoro Ellipta | 13 | $10,575 | $813 |
| Flovent Hfa | 17 | $10,511 | $618 |
| Bevespi Aerosphere | 18 | $6,935 | $385 |
| Eliquis | 29 | $6,339 | $219 |
| Wixela Inhub | 14 | $6,183 | $442 |
| Spiriva Respimat | 11 | $6,154 | $559 |
| Ventolin Hfa | 31 | $2,732 | $88 |
| Famotidine | 59 | $2,666 | $45 |
| Proair Hfa | 32 | $2,112 | $66 |
| Riluzole | 11 | $1,795 | $163 |
| Amiodarone | 15 | $1,721 | $115 |
| Glycopyrrolate | 34 | $1,609 | $47 |
| Mycophenolate Mofetil | 16 | $1,558 | $97 |
| Zolpidem | 55 | $1,532 | $28 |
| Armodafinil | 11 | $1,024 | $93 |
| Atorvastatin | 28 | $585 | $21 |
| Midodrine | 11 | $576 | $52 |
| Prednisone | 67 | $531 | $8 |
| Montelukast | 30 | $484 | $16 |
| Baclofen | 35 | $478 | $14 |
| Chlorhexidine Gluconate | 61 | $392 | $6 |
| Pantoprazole | 16 | $379 | $24 |
| Digox | 24 | $342 | $14 |
| Metformin | 11 | $321 | $29 |
| Ipratropium-Albuterol | 18 | $295 | $16 |
| Levetiracetam | 21 | $289 | $14 |
| Allopurinol | 14 | $267 | $19 |
| Ipratropium | 13 | $230 | $18 |
| Diltiazem | 14 | $226 | $16 |
| Furosemide | 33 | $226 | $7 |
| Clonazepam | 13 | $221 | $17 |
| Pramipexole Dihydrochloride | 17 | $220 | $13 |
| Trazodone | 17 | $190 | $11 |
| Warfarin | 32 | $176 | $6 |
| Levothyroxine | 18 | $155 | $9 |
| Lorazepam | 20 | $148 | $7 |
| Azithromycin | 16 | $136 | $8 |
| Metoprolol | 28 | $127 | $5 |
| Hydrochlorothiazide | 20 | $118 | $6 |
2018: 82 drugs
| Esbriet | 11 | $69,852 | $6,350 |
| Spiriva | 56 | $32,167 | $574 |
| Advair Diskus | 57 | $30,915 | $542 |
| Breo Ellipta | 59 | $28,380 | $481 |
| Levemir | 34 | $18,204 | $535 |
| Symbicort | 46 | $16,984 | $369 |
| Eliquis | 64 | $12,480 | $195 |
| Riluzole | 39 | $10,328 | $265 |
| Budesonide | 50 | $10,277 | $206 |
| Potassium Chloride | 54 | $10,223 | $189 |
| Combivent Respimat | 14 | $8,243 | $589 |
| Famotidine | 168 | $8,214 | $49 |
| Bevespi Aerosphere | 20 | $7,510 | $375 |
| Oxcarbazepine | 24 | $5,339 | $222 |
| Humulin N | 62 | $4,841 | $78 |
| Glycopyrrolate | 124 | $4,260 | $34 |
| Midodrine | 53 | $3,982 | $75 |
| Gabapentin | 38 | $3,746 | $99 |
| Levetiracetam | 101 | $3,574 | $35 |
| Proair Hfa | 50 | $3,276 | $66 |
| Amiodarone | 49 | $3,158 | $64 |
| Ventolin Hfa | 27 | $2,777 | $103 |
| Humulin R | 36 | $2,736 | $76 |
| Prevacid | 12 | $2,465 | $205 |
| Carafate | 11 | $2,250 | $205 |
| Valproic Acid | 42 | $1,905 | $45 |
| Rivastigmine | 17 | $1,715 | $101 |
| Novolog Flexpen | 14 | $1,669 | $119 |
| Baclofen | 118 | $1,633 | $14 |
| Cosopt Pf | 21 | $1,457 | $69 |
| Atorvastatin | 52 | $1,399 | $27 |
| Ipratropium-Albuterol | 57 | $1,393 | $24 |
| Chlorhexidine Gluconate | 197 | $1,278 | $6 |
| Enoxaparin | 11 | $1,193 | $108 |
| Ipratropium | 72 | $1,029 | $14 |
| Carbamazepine | 24 | $964 | $40 |
| Phenobarbital | 13 | $869 | $67 |
| Clindamycin Phosphate | 20 | $844 | $42 |
| Acetylcysteine | 15 | $818 | $55 |
| Mycophenolate Mofetil | 12 | $732 | $61 |
| Finasteride | 12 | $709 | $59 |
| Metoprolol | 131 | $701 | $5 |
| Hydrocortisone | 26 | $692 | $27 |
| Digox | 36 | $685 | $19 |
| Prednisone | 77 | $679 | $9 |
| Warfarin | 125 | $629 | $5 |
| Levothyroxine | 55 | $601 | $11 |
| Memantine | 17 | $591 | $35 |
| Zolpidem | 59 | $562 | $10 |
| Fentanyl | 12 | $502 | $42 |
| Heparin | 14 | $502 | $36 |
| Hydrocodone-Acetaminophen | 22 | $481 | $22 |
| Fluticasone Propionate | 19 | $479 | $25 |
| Furosemide | 98 | $477 | $5 |
| Montelukast | 27 | $453 | $17 |
| Hydralazine | 23 | $401 | $17 |
| Clonazepam | 40 | $374 | $9 |
| Doxazosin Mesylate | 17 | $367 | $22 |
| Allopurinol | 23 | $322 | $14 |
| Diltiazem | 21 | $305 | $15 |
| Escitalopram | 33 | $303 | $9 |
| Nystatin | 14 | $298 | $21 |
| Levofloxacin | 18 | $264 | $15 |
| Albuterol Sulfate | 18 | $243 | $14 |
| Generlac | 17 | $229 | $13 |
| Lorazepam | 17 | $223 | $13 |
| Metoclopramide | 32 | $222 | $7 |
| Methadone | 15 | $221 | $15 |
| Metformin | 15 | $220 | $15 |
| Bumetanide | 19 | $200 | $11 |
| Mupirocin | 14 | $186 | $13 |
| Pramipexole Dihydrochloride | 13 | $165 | $13 |
| Trazodone | 21 | $165 | $8 |
| Amlodipine Besylate | 27 | $160 | $6 |
| Spironolactone | 16 | $153 | $10 |
| Bisoprolol | 12 | $151 | $13 |
| Losartan | 15 | $138 | $9 |
| Venlafaxine | 11 | $136 | $12 |
| Terazosin | 12 | $107 | $9 |
| Pantoprazole | 11 | $83 | $8 |
| Hydrochlorothiazide | 14 | $71 | $5 |
| Azithromycin | 13 | $69 | $5 |
2017: 86 drugs
| Spiriva | 75 | $46,625 | $622 |
| Advair Diskus | 70 | $33,706 | $482 |
| Levemir | 44 | $18,037 | $410 |
| Budesonide | 35 | $17,566 | $502 |
| Symbicort | 44 | $16,250 | $369 |
| Potassium Chloride | 86 | $15,392 | $179 |
| Prevacid | 54 | $12,863 | $238 |
| Breo Ellipta | 35 | $11,544 | $330 |
| Anoro Ellipta | 24 | $10,679 | $445 |
| Famotidine | 178 | $9,598 | $54 |
| Oxcarbazepine | 35 | $7,597 | $217 |
| Levothyroxine | 51 | $7,013 | $138 |
| Vimpat | 14 | $6,851 | $489 |
| Dulera | 20 | $6,406 | $320 |
| Combivent Respimat | 12 | $6,183 | $515 |
| Glycopyrrolate | 132 | $5,665 | $43 |
| Ketoconazole | 39 | $5,505 | $141 |
| Riluzole | 27 | $5,095 | $189 |
| Eliquis | 22 | $4,713 | $214 |
| Levetiracetam | 138 | $4,567 | $33 |
| Gabapentin | 29 | $4,504 | $155 |
| Enoxaparin | 41 | $3,797 | $93 |
| Flovent Hfa | 11 | $3,713 | $338 |
| Midodrine | 36 | $3,485 | $97 |
| Novolog Flexpen | 28 | $3,425 | $122 |
| Carafate | 15 | $3,004 | $200 |
| Humulin N | 31 | $2,885 | $93 |
| Ipratropium-Albuterol | 118 | $2,850 | $24 |
| Valproic Acid | 47 | $2,692 | $57 |
| Proair Hfa | 45 | $2,558 | $57 |
| Oseltamivir Phosphate | 14 | $2,265 | $162 |
| Acetylcysteine | 43 | $2,081 | $48 |
| Baclofen | 125 | $1,977 | $16 |
| Ventolin Hfa | 19 | $1,825 | $96 |
| Proventil Hfa | 16 | $1,725 | $108 |
| Carbamazepine | 25 | $1,486 | $59 |
| Humulin R | 28 | $1,431 | $51 |
| Phenobarbital | 22 | $1,295 | $59 |
| Generlac | 71 | $1,188 | $17 |
| Chlorhexidine Gluconate | 142 | $1,156 | $8 |
| Humulin N Kwikpen | 11 | $1,156 | $105 |
| Amiodarone | 31 | $1,005 | $32 |
| Isosorbide Dinitrate | 15 | $1,003 | $67 |
| Atorvastatin | 51 | $996 | $20 |
| Lantus Solostar | 12 | $966 | $81 |
| Trospium Chloride | 14 | $947 | $68 |
| Clindamycin Phosphate | 14 | $870 | $62 |
| Diclofenac | 18 | $777 | $43 |
| Mupirocin | 58 | $740 | $13 |
| Hydrocortisone | 25 | $703 | $28 |
| Heparin | 13 | $700 | $54 |
| Nystatin | 29 | $674 | $23 |
| Montelukast | 29 | $589 | $20 |
| Metoclopramide | 71 | $588 | $8 |
| Prednisone | 73 | $586 | $8 |
| Metoprolol | 103 | $584 | $6 |
| Warfarin | 135 | $574 | $4 |
| Fentanyl | 14 | $561 | $40 |
| Zolpidem | 52 | $523 | $10 |
| Digox | 20 | $501 | $25 |
| Bumetanide | 22 | $482 | $22 |
| Donepezil | 15 | $482 | $32 |
| Ipratropium | 32 | $452 | $14 |
| Furosemide | 78 | $376 | $5 |
| Fluticasone Propionate | 14 | $369 | $26 |
| Methadone | 17 | $342 | $20 |
| Hydrocodone-Acetaminophen | 17 | $316 | $19 |
| Sps | 11 | $295 | $27 |
| Albuterol Sulfate | 14 | $233 | $17 |
| Venlafaxine | 13 | $204 | $16 |
| Ondansetron | 30 | $201 | $7 |
| Trazodone | 30 | $200 | $7 |
| Amlodipine Besylate | 26 | $183 | $7 |
| Hydralazine | 17 | $168 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $167 | $10 |
| Pantoprazole | 15 | $152 | $10 |
| Allopurinol | 14 | $144 | $10 |
| Atenolol | 23 | $137 | $6 |
| Carvedilol | 25 | $136 | $5 |
| Escitalopram | 13 | $133 | $10 |
| Lorazepam | 26 | $132 | $5 |
| Azithromycin | 16 | $109 | $7 |
| Levofloxacin | 13 | $105 | $8 |
| Triamcinolone Acetonide | 11 | $98 | $9 |
| Ranitidine | 11 | $71 | $6 |
| Clonazepam | 11 | $54 | $5 |
2016: 76 drugs
| Spiriva | 79 | $45,898 | $581 |
| Advair Diskus | 77 | $38,038 | $494 |
| Symbicort | 55 | $19,037 | $346 |
| Budesonide | 60 | $19,032 | $317 |
| Potassium Chloride | 80 | $13,589 | $170 |
| Prevacid | 50 | $11,192 | $224 |
| Levemir Flextouch | 51 | $11,105 | $218 |
| Levemir | 24 | $9,412 | $392 |
| Famotidine | 109 | $6,864 | $63 |
| Glycopyrrolate | 94 | $5,535 | $59 |
| Enoxaparin | 67 | $5,371 | $80 |
| Oxcarbazepine | 18 | $4,900 | $272 |
| Proair Hfa | 61 | $4,460 | $73 |
| Levetiracetam | 114 | $4,310 | $38 |
| Protonix | 15 | $4,077 | $272 |
| Gabapentin | 19 | $4,003 | $211 |
| Eliquis | 20 | $3,709 | $185 |
| Riluzole | 14 | $3,397 | $243 |
| Midodrine | 26 | $3,040 | $117 |
| Novolog | 11 | $2,870 | $261 |
| Santyl | 13 | $2,856 | $220 |
| Flovent Hfa | 13 | $2,766 | $213 |
| Novolog Flexpen | 25 | $2,737 | $109 |
| Mometasone Furoate | 14 | $2,682 | $192 |
| Ventolin Hfa | 36 | $2,351 | $65 |
| Novolin R | 16 | $2,328 | $145 |
| Ipratropium-Albuterol | 134 | $2,269 | $17 |
| Levalbuterol | 14 | $2,226 | $159 |
| Lantus Solostar | 24 | $1,952 | $81 |
| Vancomycin | 18 | $1,947 | $108 |
| Phenobarbital | 18 | $1,767 | $98 |
| Oxycodone-Acetaminophen | 19 | $1,733 | $91 |
| Nystatin | 67 | $1,678 | $25 |
| Baclofen | 55 | $1,566 | $28 |
| Carbamazepine | 24 | $1,554 | $65 |
| Valproic Acid | 31 | $1,358 | $44 |
| Humalog | 13 | $1,214 | $93 |
| Generlac | 60 | $1,088 | $18 |
| Prednisone | 102 | $958 | $9 |
| Humulin R | 18 | $926 | $51 |
| Acetylcysteine | 32 | $887 | $28 |
| Chlorhexidine Gluconate | 94 | $878 | $9 |
| Omeprazole | 31 | $832 | $27 |
| Sodium Chloride | 16 | $771 | $48 |
| Montelukast | 34 | $752 | $22 |
| Fluticasone Propionate | 33 | $697 | $21 |
| Diltiazem | 15 | $638 | $43 |
| Warfarin | 169 | $619 | $4 |
| Bumetanide | 17 | $580 | $34 |
| Zolpidem | 34 | $571 | $17 |
| Hydrocortisone | 11 | $542 | $49 |
| Atorvastatin | 32 | $485 | $15 |
| Furosemide | 85 | $460 | $5 |
| Metoprolol | 74 | $437 | $6 |
| Clonazepam | 30 | $420 | $14 |
| Triamterene-Hydrochlorothiazid | 34 | $369 | $11 |
| Digox | 16 | $364 | $23 |
| Alprazolam | 16 | $345 | $22 |
| Metoclopramide | 28 | $336 | $12 |
| Triamcinolone Acetonide | 22 | $327 | $15 |
| Albuterol Sulfate | 20 | $322 | $16 |
| Levothyroxine | 20 | $317 | $16 |
| Pramipexole Dihydrochloride | 13 | $312 | $24 |
| Mupirocin | 21 | $294 | $14 |
| Pantoprazole | 17 | $237 | $14 |
| Polyethylene Glycol 3350 | 16 | $234 | $15 |
| Ipratropium | 18 | $177 | $10 |
| Sertraline | 28 | $162 | $6 |
| Atenolol | 20 | $154 | $8 |
| Amiodarone | 13 | $149 | $11 |
| Levofloxacin | 11 | $136 | $12 |
| Carvedilol | 16 | $123 | $8 |
| Lorazepam | 15 | $122 | $8 |
| Ondansetron | 15 | $119 | $8 |
| Trazodone | 16 | $110 | $7 |
| Simvastatin | 12 | $67 | $6 |
2015: 73 drugs
| Spiriva | 73 | $44,350 | $608 |
| Advair Diskus | 67 | $33,228 | $496 |
| Symbicort | 29 | $11,319 | $390 |
| Levemir | 31 | $8,668 | $280 |
| Budesonide | 30 | $8,042 | $268 |
| Advair Hfa | 15 | $7,943 | $530 |
| Novolog | 21 | $6,669 | $318 |
| Potassium Chloride | 67 | $5,535 | $83 |
| Gabapentin | 42 | $4,827 | $115 |
| Enoxaparin | 53 | $4,755 | $90 |
| Protonix | 19 | $4,286 | $226 |
| Oxcarbazepine | 23 | $4,012 | $174 |
| Prevacid | 19 | $3,511 | $185 |
| Duloxetine | 24 | $3,384 | $141 |
| Glycopyrrolate | 87 | $3,157 | $36 |
| Flovent Hfa | 14 | $3,062 | $219 |
| Lantus | 11 | $2,897 | $263 |
| Qvar | 15 | $2,758 | $184 |
| Humalog | 11 | $2,494 | $227 |
| Levetiracetam | 65 | $2,472 | $38 |
| Riluzole | 16 | $2,446 | $153 |
| Ventolin Hfa | 30 | $2,441 | $81 |
| Ipratropium-Albuterol | 104 | $2,342 | $23 |
| Santyl | 11 | $2,282 | $207 |
| Proair Hfa | 41 | $2,186 | $53 |
| Midodrine | 14 | $2,124 | $152 |
| Phenobarbital | 17 | $2,121 | $125 |
| Heparin | 29 | $1,602 | $55 |
| Baclofen | 54 | $1,500 | $28 |
| Carbamazepine | 24 | $1,403 | $58 |
| Valproic Acid | 45 | $1,070 | $24 |
| Famotidine | 53 | $1,008 | $19 |
| Montelukast | 25 | $925 | $37 |
| Nystatin | 30 | $804 | $27 |
| Sodium Chloride | 16 | $750 | $47 |
| Prednisone | 91 | $737 | $8 |
| Hydrocortisone | 18 | $661 | $37 |
| Zolpidem | 40 | $629 | $16 |
| Methadone | 16 | $578 | $36 |
| Furosemide | 93 | $571 | $6 |
| Warfarin | 130 | $543 | $4 |
| Fluticasone Propionate | 45 | $521 | $12 |
| Generlac | 31 | $429 | $14 |
| Oxycodone | 12 | $403 | $34 |
| Levofloxacin | 14 | $383 | $27 |
| Chlorhexidine Gluconate | 49 | $381 | $8 |
| Polyethylene Glycol 3350 | 26 | $348 | $13 |
| Triamcinolone Acetonide | 27 | $331 | $12 |
| Metoprolol | 54 | $295 | $5 |
| Morphine Sulfate | 15 | $288 | $19 |
| Amlodipine Besylate | 43 | $284 | $7 |
| Triamterene-Hydrochlorothiazid | 19 | $219 | $12 |
| Hydrocodone-Acetaminophen | 16 | $212 | $13 |
| Amiodarone | 19 | $208 | $11 |
| Mupirocin | 20 | $202 | $10 |
| Tizanidine | 12 | $190 | $16 |
| Amoxicillin-Clavulanate Potass | 11 | $174 | $16 |
| Torsemide | 12 | $170 | $14 |
| Levothyroxine | 13 | $167 | $13 |
| Lorazepam | 16 | $165 | $10 |
| Atenolol | 27 | $162 | $6 |
| Carvedilol | 14 | $159 | $11 |
| Diltiazem | 12 | $143 | $12 |
| Simvastatin | 29 | $132 | $5 |
| Metoclopramide | 16 | $126 | $8 |
| Ondansetron | 11 | $105 | $10 |
| Clonazepam | 19 | $100 | $5 |
| Nortriptyline | 11 | $92 | $8 |
| Pantoprazole | 12 | $91 | $8 |
| Alprazolam | 13 | $75 | $6 |
| Trazodone | 14 | $68 | $5 |
| Lisinopril | 11 | $48 | $4 |
| Losartan | 12 | $38 | $3 |
2014: 70 drugs
| Spiriva | 98 | $48,407 | $494 |
| Advair Diskus | 80 | $37,016 | $463 |
| Levemir | 58 | $13,512 | $233 |
| Symbicort | 32 | $12,884 | $403 |
| Enoxaparin | 129 | $12,394 | $96 |
| Gabapentin | 84 | $9,891 | $118 |
| Novolog | 35 | $7,985 | $228 |
| Budesonide | 38 | $7,707 | $203 |
| Modafinil | 11 | $6,819 | $620 |
| Metaxalone | 16 | $4,779 | $299 |
| Trileptal | 17 | $4,736 | $279 |
| Duloxetine | 23 | $4,683 | $204 |
| Restasis | 22 | $4,008 | $182 |
| Flovent Hfa | 18 | $3,889 | $216 |
| Oxcarbazepine | 16 | $3,528 | $220 |
| Xarelto | 26 | $3,400 | $131 |
| Qvar | 18 | $3,263 | $181 |
| Dulera | 12 | $2,920 | $243 |
| Demeclocycline | 12 | $2,560 | $213 |
| Midodrine | 18 | $2,554 | $142 |
| Ventolin Hfa | 27 | $2,505 | $93 |
| Prilosec | 18 | $2,443 | $136 |
| Levetiracetam | 62 | $2,294 | $37 |
| Phenobarbital | 47 | $2,290 | $49 |
| Proair Hfa | 39 | $2,282 | $59 |
| Potassium Chloride | 49 | $1,884 | $38 |
| Proventil Hfa | 13 | $1,733 | $133 |
| Ipratropium-Albuterol | 73 | $1,682 | $23 |
| Famotidine | 78 | $1,580 | $20 |
| Glycopyrrolate | 62 | $1,501 | $24 |
| Montelukast | 17 | $1,287 | $76 |
| Carbamazepine | 22 | $1,199 | $55 |
| Protonix | 11 | $1,137 | $103 |
| Azelastine | 17 | $937 | $55 |
| Generlac | 68 | $889 | $13 |
| Baclofen | 34 | $880 | $26 |
| Polyethylene Glycol 3350 | 56 | $831 | $15 |
| Valproic Acid | 37 | $798 | $22 |
| Tizanidine | 18 | $768 | $43 |
| Prednisone | 86 | $730 | $8 |
| Warfarin | 112 | $614 | $5 |
| Hydrocortisone | 23 | $545 | $24 |
| Chlorhexidine Gluconate | 60 | $541 | $9 |
| Oxybutynin Chloride | 13 | $477 | $37 |
| Hydrocodone-Acetaminophen | 43 | $477 | $11 |
| Furosemide | 66 | $445 | $7 |
| Diltiazem | 32 | $419 | $13 |
| Amox Tr-Potassium Clavulanate | 12 | $393 | $33 |
| Methadone | 19 | $393 | $21 |
| Digox | 18 | $376 | $21 |
| Triamterene-Hydrochlorothiazid | 36 | $346 | $10 |
| Fluticasone Propionate | 31 | $343 | $11 |
| Metoprolol | 38 | $322 | $8 |
| Nystatin | 12 | $315 | $26 |
| Zolpidem | 40 | $274 | $7 |
| Clonazepam | 40 | $256 | $6 |
| Metoclopramide | 21 | $223 | $11 |
| Lorazepam | 25 | $210 | $8 |
| Atorvastatin | 12 | $186 | $15 |
| Atenolol | 27 | $178 | $7 |
| Fluoxetine | 18 | $156 | $9 |
| Torsemide | 11 | $154 | $14 |
| Ropinirole | 14 | $145 | $10 |
| Clonidine | 18 | $143 | $8 |
| Nortriptyline | 13 | $114 | $9 |
| Bupropion Hcl Sr | 11 | $112 | $10 |
| Amlodipine Besylate | 18 | $108 | $6 |
| Diazepam | 22 | $84 | $4 |
| Alprazolam | 12 | $66 | $5 |
| Losartan | 12 | $37 | $3 |
2013: 41 drugs
| Advair Diskus | 122 | $47,291 | $388 |
| Spiriva | 92 | $41,204 | $448 |
| Enoxaparin | 77 | $11,703 | $152 |
| Symbicort | 20 | $7,805 | $390 |
| Combivent | 17 | $4,712 | $277 |
| Demeclocycline | 13 | $4,266 | $328 |
| Combivent Respimat | 14 | $4,099 | $293 |
| Budesonide | 17 | $3,508 | $206 |
| Gabapentin | 45 | $3,076 | $68 |
| Midodrine | 23 | $2,963 | $129 |
| Proair Hfa | 51 | $2,681 | $53 |
| Levetiracetam | 33 | $2,058 | $62 |
| Montelukast | 21 | $1,935 | $92 |
| Ventolin Hfa | 25 | $1,630 | $65 |
| Phenobarbital | 36 | $1,330 | $37 |
| Azelastine | 16 | $1,272 | $80 |
| Famotidine | 44 | $1,202 | $27 |
| Ipratropium-Albuterol | 28 | $1,154 | $41 |
| Glycopyrrolate | 28 | $884 | $32 |
| Valproic Acid | 38 | $675 | $18 |
| Carbamazepine | 16 | $593 | $37 |
| Fentanyl | 12 | $546 | $45 |
| Fluticasone Propionate | 23 | $504 | $22 |
| Polyethylene Glycol 3350 | 30 | $496 | $17 |
| Generlac | 28 | $448 | $16 |
| Hydrocortisone | 13 | $418 | $32 |
| Prednisone | 81 | $398 | $5 |
| Metoclopramide | 24 | $375 | $16 |
| Clonazepam | 39 | $357 | $9 |
| Methadone | 26 | $319 | $12 |
| Chlorhexidine Gluconate | 30 | $307 | $10 |
| Potassium Chloride | 21 | $306 | $15 |
| Triamterene-Hctz | 29 | $254 | $9 |
| Zolpidem | 32 | $208 | $6 |
| Furosemide | 25 | $156 | $6 |
| Baclofen | 11 | $136 | $12 |
| Warfarin | 20 | $135 | $7 |
| Lorazepam | 13 | $73 | $6 |
| Atenolol | 12 | $69 | $6 |
| Amlodipine Besylate | 11 | $57 | $5 |
| Amitriptyline | 12 | $47 | $4 |
Money from drug and device companies
$947 in 2025
| 2025 | 13 | 38 | None | $947 |
| 2024 | 11 | 36 | None | $927 |
| 2023 | 15 | 44 | None | $1,077 |
| 2022 | 7 | 13 | None | $346 |
| 2021 | 6 | 17 | None | $268 |
| 2020 | 3 | 3 | None | $55 |
| 2019 | 6 | 17 | None | $252 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Xywav | $278 | 8 payments
|
| Inspire Medical Systems | Inspire | $266 | 11 payments
|
| Harmony Biosciences | Wakix | $77 | 3 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $63 | 3 payments
|
| Axsome Therapeutics | Sunosi | $52 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $40 | 2 payments
|
See all 37 published payments
| Avadel CNS Pharmaceuticals | Meals · 2025-12-16 | Lumryz | $21 |
| Harmony Biosciences | Meals · 2025-12-13 | Wakix | $27 |
| Jazz Pharmaceuticals | Meals · 2025-12-12 | Xywav | $146 |
| Jazz Pharmaceuticals | Meals · 2025-12-04 | Xywav | $13 |
| Inspire Medical Systems | Meals · 2025-12-03 | Inspire | $8 |
| Jazz Pharmaceuticals | Meals · 2025-11-18 | Xywav | $9 |
| Inspire Medical Systems | Meals · 2025-11-12 | Inspire | $141 |
| Jazz Pharmaceuticals | Meals · 2025-10-28 | Xywav | $23 |
| Xeris Pharmaceuticals | Meals · 2025-10-28 | Recorlev | $20 |
| Inspire Medical Systems | Meals · 2025-10-08 | Inspire | $8 |
| Axsome Therapeutics | Meals · 2025-09-26 | Sunosi | $16 |
| Jazz Pharmaceuticals | Meals · 2025-09-19 | Xywav | $13 |
| Inspire Medical Systems | Meals · 2025-09-10 | Inspire | $13 |
| Fresenius Kabi USA | Meals · 2025-09-03 | None | $35 |
| Inspire Medical Systems | Meals · 2025-08-11 | Inspire | $13 |
| Inspire Medical Systems | Meals · 2025-07-30 | Inspire | $8 |
| Axsome Therapeutics | Meals · 2025-07-22 | Sunosi | $18 |
| Harmony Biosciences | Meals · 2025-07-14 | Wakix | $28 |
| Jazz Pharmaceuticals | Meals · 2025-07-08 | Xywav | $34 |
| Inspire Medical Systems | Meals · 2025-06-30 | Inspire | $12 |
| Inspire Medical Systems | Meals · 2025-06-17 | Inspire | $17 |
| Inspire Medical Systems | Meals · 2025-06-16 | Inspire | $7 |
| Novo Nordisk | Meals · 2025-06-04 | Wegovy | $29 |
| Axsome Therapeutics | Meals · 2025-06-03 | Sunosi | $19 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $18 |
| Inspire Medical Systems | Meals · 2025-04-25 | Inspire | $14 |
| Lilly USA | Meals · 2025-03-27 | Mounjaro | $15 |
| GlaxoSmithKline | Meals · 2025-03-21 | Trelegy Ellipta | $23 |
| Avadel CNS Pharmaceuticals | Meals · 2025-03-19 | Lumryz | $28 |
| Jazz Pharmaceuticals | Meals · 2025-03-18 | Xywav | $8 |
| Insmed | Meals · 2025-03-14 | Arikayce | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-06 | None | $20 |
| Inspire Medical Systems | Meals · 2025-02-20 | Inspire | $25 |
| Avadel CNS Pharmaceuticals | Meals · 2025-02-12 | Lumryz | $14 |
| Jazz Pharmaceuticals | Meals · 2025-01-17 | Xywav | $32 |
| Harmony Biosciences | Meals · 2025-01-08 | Wakix | $23 |
| Dexcom | Meals · 2025-01-06 | Dexcom G6 Transmitter | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $927
| Jazz Pharmaceuticals | Xywav | $244 | 8 payments
|
| Inspire Medical Systems | Inspire | $231 | 7 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $139 | 7 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $88 | 5 payments
|
| Vanda Pharmaceuticals | Hetlioz | $62 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $45 | 1 payment
|
| Electromed | Smartvest | $36 | 2 payments
|
| Axsome Therapeutics | Sunosi | $31 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $21 | 1 payment
|
| Genzyme | Dupixent | $17 | 1 payment
|
| ZOLL Respicardia | Remede System | $13 | 1 payment
|
2023: $1,077
| Inspire Medical Systems | Inspire | $177 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $171 | 9 payments
|
| Resmed | Airsense | $137 | 2 payments
|
| Harmony Biosciences | Wakix | $130 | 9 payments
|
| Jazz Pharmaceuticals | Xywav | $114 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $103 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $56 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $54 | 3 payments
|
| Axsome Therapeutics | Sunosi | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $24 | 1 payment
|
| Insmed | Arikayce | $20 | 1 payment
|
| Inogen | Inogen One G5 Oxygen Concentrator - Bluetooth | $16 | 1 payment
|
| Electromed | Smartvest | $16 | 1 payment
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $15 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $13 | 1 payment
|
2022: $346
| GlaxoSmithKline | Trelegy Ellipta | $142 | 3 payments
|
| Harmony Biosciences | Wakix | $90 | 4 payments
|
| Jazz Pharmaceuticals | Xywav | $40 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $21 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $18 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $17 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $17 | 1 payment
|
2021: $268
| GlaxoSmithKline | Trelegy Ellipta | $159 | 11 payments
|
| Pulmonx | Chartis Catheter | $40 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $24 | 1 payment
|
| Resmed | Airsense | $19 | 1 payment
|
| Amgen | None | $13 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $13 | 1 payment
|
2020: $55
| Advanced Respiratory | The Vest System Model 105 Home Care | $24 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $11 | 1 payment
|
2019: $252
| AstraZeneca Pharmaceuticals LP | Symbicort | $69 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $50 | 2 payments
|
| Genentech USA | Esbriet | $34 | 2 payments
|
| GlaxoSmithKline | Nucala | $33 | 2 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $33 | 4 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $33 | 3 payments
|
Professional record
- NPI
- 1306895313
- Licence
- CA G26701, CA G267010California G26701: Current · expires 2027-10-31
- Trained
- University of California, Davis School of Medicine, 1972 · 54 years ago
- Group
- Jiva Health Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G267010
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 130 La Casa Via, Bldg #2, Suite 208, Walnut Creek, CA, 94598
- NPI first listed
- 2006-05-08
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.